EA200000672A1 - Кристалический терипаратид - Google Patents

Кристалический терипаратид

Info

Publication number
EA200000672A1
EA200000672A1 EA200000672A EA200000672A EA200000672A1 EA 200000672 A1 EA200000672 A1 EA 200000672A1 EA 200000672 A EA200000672 A EA 200000672A EA 200000672 A EA200000672 A EA 200000672A EA 200000672 A1 EA200000672 A1 EA 200000672A1
Authority
EA
Eurasian Patent Office
Prior art keywords
teriparatide
crystal
purification
preparation
methods
Prior art date
Application number
EA200000672A
Other languages
English (en)
Inventor
Фэминг Занг
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA200000672A1 publication Critical patent/EA200000672A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)

Abstract

(57) Описаны очищенный стабильный паратиреоидный гормон, в частности терипаратид, в кристаллическом состоянии, а также способы его получения и очистки.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200000672A 1997-12-18 1998-12-08 Кристалический терипаратид EA200000672A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6987597P 1997-12-18 1997-12-18
PCT/US1998/026044 WO1999031137A1 (en) 1997-12-18 1998-12-08 Crystalline teriparatide

Publications (1)

Publication Number Publication Date
EA200000672A1 true EA200000672A1 (ru) 2000-12-25

Family

ID=22091750

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000672A EA200000672A1 (ru) 1997-12-18 1998-12-08 Кристалический терипаратид

Country Status (24)

Country Link
US (1) US6590081B1 (ru)
EP (1) EP0926158B1 (ru)
JP (1) JP2002508395A (ru)
KR (1) KR20010033268A (ru)
CN (1) CN1281467A (ru)
AR (1) AR038648A1 (ru)
AT (1) ATE245165T1 (ru)
AU (1) AU748271B2 (ru)
BR (1) BR9813740A (ru)
CA (1) CA2315103A1 (ru)
DE (1) DE69816409T2 (ru)
DK (1) DK0926158T3 (ru)
EA (1) EA200000672A1 (ru)
ES (1) ES2202729T3 (ru)
HU (1) HUP0100075A2 (ru)
ID (1) ID25660A (ru)
IL (1) IL136824A0 (ru)
NO (1) NO20003131D0 (ru)
PE (1) PE20000056A1 (ru)
PL (1) PL341209A1 (ru)
PT (1) PT926158E (ru)
TR (1) TR200002179T2 (ru)
WO (1) WO1999031137A1 (ru)
ZA (1) ZA9811407B (ru)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601685B2 (en) 1998-08-27 2009-10-13 Eidgenossische Technische Hochschule Zurich Growth factor modified protein matrices for tissue engineering
EP1864681A1 (en) 2001-12-18 2007-12-12 Eidgenössische Technische Hochschule Zürich Growth factor modified protein matrices for tissue engineering
BRPI0215192B8 (pt) * 2001-12-18 2021-07-27 Eidgenoessische Technische Hochschule Zuerich peptídeo de fusão, kit e matriz que compreendem o mesmo, e método para criar uma matriz
US7247609B2 (en) 2001-12-18 2007-07-24 Universitat Zurich Growth factor modified protein matrices for tissue engineering
WO2004022033A1 (en) * 2002-09-04 2004-03-18 Microchips, Inc. Method and device for the controlled delivery of parathyroid hormone
SG176314A1 (en) 2002-12-31 2011-12-29 Altus Pharmaceuticals Inc Human growth hormone crystals and methods for preparing them
US8088734B2 (en) 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
US7429378B2 (en) * 2003-05-13 2008-09-30 Depuy Spine, Inc. Transdiscal administration of high affinity anti-MMP inhibitors
US7553827B2 (en) * 2003-08-13 2009-06-30 Depuy Spine, Inc. Transdiscal administration of cycline compounds
US20040229878A1 (en) * 2003-05-13 2004-11-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of P38 kinase
US8273347B2 (en) 2003-05-13 2012-09-25 Depuy Spine, Inc. Autologous treatment of degenerated disc with cells
US7344716B2 (en) * 2003-05-13 2008-03-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
US8361467B2 (en) * 2003-07-30 2013-01-29 Depuy Spine, Inc. Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
US8895540B2 (en) * 2003-11-26 2014-11-25 DePuy Synthes Products, LLC Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
US20060052305A1 (en) * 2004-05-10 2006-03-09 Nastech Pharmaceutical Company Inc. Method of treating osteoporosis using intranasal parathyroid hormone
US20060127320A1 (en) * 2004-05-10 2006-06-15 Nastech Pharmaceutical Company Inc. Method of delivering parathyroid hormone to a human
US7244709B2 (en) * 2004-05-10 2007-07-17 Nastech Pharamecutical Company Inc. Compositions and methods for enhanced mucosal delivery of parathyroid hormone
AU2005244734A1 (en) 2004-05-13 2005-12-01 Alza Corporation Apparatus and method for transdermal delivery of parathyroid hormone agents
WO2006073711A2 (en) 2005-01-06 2006-07-13 Kuros Biosurgery Ag Use of a matrix comprising a contrast agent in soft tissues
US8575101B2 (en) 2005-01-06 2013-11-05 Kuros Biosurgery Ag Supplemented matrices for the repair of bone fractures
US7691105B2 (en) 2005-09-26 2010-04-06 Depuy Spine, Inc. Tissue augmentation, stabilization and regeneration technique
US20070088436A1 (en) * 2005-09-29 2007-04-19 Matthew Parsons Methods and devices for stenting or tamping a fractured vertebral body
US20070173447A1 (en) * 2005-10-25 2007-07-26 Nastech Pharmaceutical Company Inc. Method for treating osteoporosis by intranasal delivery of teriparatide with an anti-resorptive agent
WO2007059470A2 (en) * 2005-11-10 2007-05-24 Board Of Control Of Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
US20080051332A1 (en) * 2005-11-18 2008-02-28 Nastech Pharmaceutical Company Inc. Method of modulating hematopoietic stem cells and treating hematologic diseases using intranasal parathyroid hormone
US20070168041A1 (en) * 2006-01-17 2007-07-19 Sudhakar Kadiyala Method and instruments for intervertebral disc augmentation through a pedicular approach
CN101711168B (zh) 2007-04-13 2013-05-01 库罗斯生物外科股份公司 聚合物组织封闭剂
EP2173768B1 (en) * 2007-08-09 2014-03-05 USV Limited Novel orthogonal process for purification of recombinant human parathyroid hormone (rhpth) (1-34)
TW200930343A (en) * 2007-09-21 2009-07-16 Organon Nv Drug delivery system
US8241363B2 (en) 2007-12-19 2012-08-14 Depuy Spine, Inc. Expandable corpectomy spinal fusion cage
US8241294B2 (en) 2007-12-19 2012-08-14 Depuy Spine, Inc. Instruments for expandable corpectomy spinal fusion cage
US8986696B2 (en) * 2007-12-21 2015-03-24 Depuy Mitek, Inc. Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
US20090162351A1 (en) * 2007-12-21 2009-06-25 Depuy Spine, Inc. Transdiscal administration of inhibitors of p38 MAP kinase
WO2009083544A2 (en) 2007-12-28 2009-07-09 Kuros Biosurgery Ag Pdgf fusion proteins incorporated into fibrin foams
US8876905B2 (en) 2009-04-29 2014-11-04 DePuy Synthes Products, LLC Minimally invasive corpectomy cage and instrument
JP2013512688A (ja) 2009-12-07 2013-04-18 ミシガン テクノロジカル ユニバーシティ クロクマの副甲状腺ホルモン及びクロクマの副甲状腺ホルモンを使用する方法
US8865220B2 (en) 2010-06-14 2014-10-21 Kaohsiung Medical University Method for controlled release of parathyroid hormone from encapsulated poly(lactic-glycolic)acid microspheres
WO2012123028A1 (en) 2011-03-16 2012-09-20 Kuros Biosurgery Ag Pharmaceutical formulation for use in spinal fusion
CN102731643A (zh) * 2012-06-26 2012-10-17 深圳翰宇药业股份有限公司 一种治疗骨质疏松多肽的制备方法
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
US10596103B2 (en) 2013-12-11 2020-03-24 Merek Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
CN104910269B (zh) * 2015-06-02 2018-08-17 成都圣诺生物科技股份有限公司 一种合成特立帕肽的方法
JP6577683B2 (ja) * 2017-09-22 2019-09-18 旭化成ファーマ株式会社 安定性に優れるテリパラチド含有液状医薬組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62106000A (ja) 1985-10-30 1987-05-16 Fujitsu Ltd 生体高分子結晶自動作製装置
EP0415924B1 (en) * 1987-10-20 1996-05-29 HOLICK, Michael F Regulation of cell proliferation and differentiation using peptides
MX9205727A (es) 1991-10-09 1993-04-01 Schering Corp Dispositivo para la formacion de cristales y sistema automatizado de cristalizacion
US5400741A (en) * 1993-05-21 1995-03-28 Medical Foundation Of Buffalo, Inc. Device for growing crystals
US5496801A (en) * 1993-12-23 1996-03-05 Allelix Biopharmaceuticals Inc. Parathyroid hormone formulation
US5419278A (en) * 1994-05-25 1995-05-30 Carter; Daniel C. Vapor equilibration tray for growing protein crystals
CA2178894A1 (en) 1995-06-15 1996-12-16 Tsunehiko Fukuda Parathyroid hormone derivatives and their use

Also Published As

Publication number Publication date
TR200002179T2 (tr) 2001-07-23
AR038648A1 (es) 2005-01-26
EP0926158B1 (en) 2003-07-16
ID25660A (id) 2000-10-19
NO20003131L (no) 2000-06-16
DE69816409T2 (de) 2004-06-09
ES2202729T3 (es) 2004-04-01
PT926158E (pt) 2003-11-28
BR9813740A (pt) 2000-10-10
NO20003131D0 (no) 2000-06-16
AU748271B2 (en) 2002-05-30
DE69816409D1 (de) 2003-08-21
EP0926158A1 (en) 1999-06-30
IL136824A0 (en) 2001-06-14
KR20010033268A (ko) 2001-04-25
WO1999031137A1 (en) 1999-06-24
JP2002508395A (ja) 2002-03-19
HUP0100075A2 (hu) 2001-05-28
AU1632699A (en) 1999-07-05
CA2315103A1 (en) 1999-06-24
DK0926158T3 (da) 2003-11-10
PE20000056A1 (es) 2000-02-08
US6590081B1 (en) 2003-07-08
ATE245165T1 (de) 2003-08-15
CN1281467A (zh) 2001-01-24
PL341209A1 (en) 2001-03-26
ZA9811407B (en) 2000-07-13

Similar Documents

Publication Publication Date Title
EA200000672A1 (ru) Кристалический терипаратид
DE69431333T2 (de) GaN-Einkristall
DE69311289T2 (de) Photovoltaische zelle
FI945069A (fi) Nestekideyhdisteet, joissa on perfluorieetteripääteosat
KR960702937A (ko) 비정질 다이아몬드막 플랫 필드 방출캐소드(amorphic diamond film flat field emission cathode)
EA200100194A1 (ru) КРИСТАЛЛИЧЕСКИЕ ФОРМЫ ETO2C-CH2-(R)Cgl-Aze-Pab-OH
DE3778920D1 (de) Mikrorechner mit betriebsarten fuer hohe und fuer geringe taktrate.
FI906078A0 (fi) Flytande kristall ihopkopplad med diklorin faergaemne.
BR9408087A (pt) Recuperação de um aminoácido
NO953502D0 (no) Renseblandinger med kortkjedede ikke-ioniske overflateaktive midler
ES2150233T3 (es) Pirrolo(2,3-c)carbazol-6-onas condensadas que potencian la actividad de interferon gamma.
TR199802394A3 (tr) Proteinleri stabilize etmek için gelistirilmis proses.
DE69528051T2 (de) Kristallwachstumsverfahren
BR9007992A (pt) Processo para recuperar proteinas recombinantes
DK101291D0 (da) Phosphatfrit, flydende vaskemiddel med hoej alkalinitet
DK0640608T3 (da) Mellemprodukter til syntese af cephalosporiner
EA200000069A1 (ru) Способ получения 4-замещенных-1h-индол-3-глиоксамидов
BR9402493A (pt) Composição de micro-emulsão ácida
FI961287A0 (fi) Itsepaistuva hiilielektrodi
FR2655308B1 (fr) Bicyclette de haute performance.
BR9810792A (pt) Processo para purificar óxido de propileno por destilação, uso de um óxido de propileno, polìmero produzido usando óxido de propileno purificado, e, poliuretano
EA200000946A1 (ru) Кристаллическая форма пароксетина
KR940000965U (ko) 정량 눈새김 연료운반통
DE3871737D1 (de) Hochspannungserzeuger fuer fernsehgeraete.
KR970006862U (ko) 생각하는 시계(iq. 향상 시계)